Key Market Indicators
Sales of antidepressant medications in Australia are projected to climb to approximately $452 million by 2028, up from around $425 million in 2023. This marks an average annual growth rate of 1%. Since 1995, the Australian market for these medicines has seen an average yearly increase of 5%. Despite this steady growth, Australia ranked fourth in the global market for antidepressant sales in 2023. Italy has surpassed Australia, matching its sales at $425 million. Spain and Italy secured the second and third positions, respectively, in this ranking.
